Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.
------------------------------------------------------------
November 25, 2002
U.S. IMMUNIZATION NEWS
"Researchers Looking for Women for Cervical Cancer Study" Associated Press (www.ap.org) (11/24/02)
Women who are virgins or have a limited number of sexual partners are needed for the final phase of clinical studies involving a cervical cancer vaccine. About 70 women between the ages of 16 years and 23 years participated in the second phase of clinical trials that determined that the vaccine is safe and effective in the prevention of cervical cancer. Women taking the vaccine were shown to resist the human papilloma virus, which infects the cervix and often leads to cervical cancer, while women taking the placebo were more at risk of contracting the virus. Merck, which financed the studies, produces the new vaccine and plans to launch the product in several years to prevent the 4,500 deaths related to cervical cancer each year.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.